The objective of the present study was to evaluate the efficacy of a sclerosing solution for inducing epididymal occlusion in male rats.
INTRODUCTION
Vasectomy is a simple and popular surgical procedure that is used as a permanent birth control method for men. During the procedure, the vasa deferentia of a man are taken out and then, tied or sealed to prevent the sperm from entering into the semen. This is a widely used birth control method for men because of its high success rate and low complication rate. However, the fear of skin incision or cutting of the vasa deferentia and the male genital organs prevents many men from undergoing vasectomy. Therefore, several studies [1] [2] [3] have been conducted on inducing sterilization without surgery. In these studies, injection therapy inducing vasal or epididymal occlusion has shown some efficacy, but the results have been inconsistent.
Although previously, the ligation and removal of en- gorged veins was the most widely used surgical method for varicose veins in the legs, with the development of various occlusive agents, simple injection therapy now plays a major role in the treatment of varicose veins [4] [5] [6] . The mechanism of action of an occlusive agent is the induction of an epithelial cell injury and fibrosis and finally, the occlusion of the vein lumen [7] .
As the lumen of the epididymis is lined by epithelium similar to that in veins, the occlusive agent is expected to have a similar effect, that is, luminal occlusion. If the drug has a similar occlusive effect on the vas deferens or epididymis, this injection therapy could replace vasectomy.
The objective of the present study was to evaluate the safety and efficacy of a sclerosing solution, sodium tetradecyl sulfate (STS) for inducing epididymal occlusion in male rats.
MATERIALS AND METHODS
We used a total of 40 male Sprague-Dawley rats (6-week-old male rats) in this study. All the animal experiments were conducted according to the guidelines of the Animal Institutional Review Board of Konkuk University. These rats were selected because of the easy access to the epididymis and semen collection.
Twenty rats were used as controls, and 20 rats were included in the injection group, in which sterility would be induced by using the STS solution.
Two weeks before semen collection, the seminal vesicles were excised via a midline incision after anesthesia.
An electrostimulation method was used for semen collection, as described in detail in a previous study [8] . With a transrectal probe (60 Hz, 3 V, 0.5 A), sine-wave electrostimulation was applied to the rectum of an anesthetized rat. The urethral meatus was seen when the prepuce was retracted. The semen found at the meatus was collected by a pipette, and the presence of sperms was confirmed under a microscope.
Induction of ejaculation was achieved in all of the rats, and the presence of sperms in the semen was confirmed in these rats (Fig. 1B) .
After an analysis of the semen, 0.2 mL of 0.1% STS solution was injected into the epididymis with a 24 G syringe in the rats of the injection group. Under general anesthesia, we exposed the rats' epididymis and injected about 0.2 mL of the STS solution in both the head and the tail of the epididymis (a total of 0.4 mL on one side). The epididymis of the rats in the control group was identified, but no additional procedure was performed. There was no difficulty in injecting the sclerosing agent, and after injection, the testis and the epididymis were pulled back into the scrotum.
After 4 weeks and 12 weeks of injection, the 2nd and the 3rd semen collections were performed by the electrical stimulation method. The presence of sperms was evaluated by two examiners who were unaware of the group identity.
Autopsies were performed shortly after taking the final semen sample. The epididymis was excised and fixed in 4% neutral buffered formalin and subjected to paraffin embedding for further sectioning. Hematoxylin and eosin (H&E) staining was performed to detect any structural anomaly of the epididymis. 
RESULTS

Semen analysis
After 4 weeks and 12 weeks of injection, the induction of ejaculation was achieved in both the groups.
The rats of the control group showed sperms in the semen (Fig. 1B) . However, no sperms were observed in the semen of rats from the injection group (Fig. 1C ). There were no cases of testicular atrophy or swelling in the two groups.
Pathology
The epididymis of the rats in the injection group was slightly swollen as compared to that of rats in the normal control group. However, there was no abscess formation.
H&E staining showed an infiltration of inflammatory cells in the epididymis of the rats in the injection group. The epididymis was swollen grossly, and leukocytes were infiltrated in the epididymal tubules and stroma. An obstruction of the epididymal tubules was observed in the rats of the injection group. Inflammation or obstruction of the epididymal tubules was not seen in the rats of the normal control group (Fig. 2) .
DISCUSSION
Vasectomy has been proved to be a safe and efficacious method of male sterilization.
However, the thought of someone operating on their genital organs generates fear in many men, and this is the main reason why men do not want to undergo vasectomy. Therefore, the induction of sterilization by injection and without surgery could be more acceptable to these men.
The mechanism of action of injection therapy is that when a drug is injected into the epididymis or the vas deferens, it occludes the epididymal lumen or the vas deferens and prevents sperm movement. Another mechanism of action of injection therapy is the prevention of sperm formation in the testis when a drug is injected into the testis. As zinc-based solutions have been effective in the prevention of sperm formation in the testis [9] , a zinc-based solution, Neutersol Ⓡ , is now used as an agent for sterilization, and the Food and Drug Administration (FDA), USA, has approved its use for the sterilization of dogs. However, it has not been approved for male sterilization, and there is no report about its long-term effect on the testis.
In contrast to testicular injection that induces the prevention of sperm formation, epididymal or vasal injection therapy has not been used widely. Fahim et al [2] reported a sterilization rate of 100% in 15 dogs that received an epididymal injection of zinc arginine. However, a study by Singh et al [3] did not show similar effectiveness after vasal injection. Thus far, the FDA has not approved any agent that induces the occlusion of the epididymis or the vas deferens.
Sclerotherapy has been used for centuries to treat spider veins. The technique involves the injection of a chemical into the veins.
Sclerosants are injectable chemical agents that can scarify and obliterate the vascular tissue. A liquid or foam sclerosing agent is injected into the vein to cause localized damage to the inner lining (endothelium) of the vein. This leads to inflammation, collapse, and thickening or scarring of the vessel. STS is a widely used sclerosant for the treatment of telangiectatic veins and has been approved for use in the United States by the FDA.
We assumed that this sclerosing agent could cause damage to the epididymal endothelium and may cause obliteration as in the veins.
This study showed that the injection of STS into the epididymal tubules induced sterilization in male rats and that the sterilization was achieved due to the occlusion of the epididymal tubules. This is the first study to show that STS may be an effective agent for male contraception.
After performing more studies, this injection therapy could be used for an induction of sterilization in dogs and cats that need to undergo vasectomy or orchiectomy. Moreover, after performing clinical trials, we expect this injection therapy toplayan important role in male contraception.
This study has several limitations. First, we determined that there were no sperms in the semen at only 4 and 12 weeks. The efficacy of the sclerosing agent is reported to be more than 90%, but re-canalization occurs sometimes in the great veins such as the saphenous vein [10] . As continuous blood flow differs from an intermittent small amount of vasal fluid, there is a much lower possibility of recurrence. However, this must be evaluated by a large long-term study.
Further, a confirmation of the absence of pregnancy after mating is needed to further strengthen these results.
Secondly, epididymal tubular damage-related pain or inflammation needs to be evaluated to apply these results in a larger animal or human study.
This study is a preliminary short-term study of rats. Therefore, a further study of large animals and a clinical study are needed. Moreover, the long-term effectiveness of this method needs to be studied.
Despite these limitations, this study is meaningful a sit shows that a simple and effective method of contraception without surgery is possible.
CONCLUSIONS
This study demonstrated sclerosing agent-induced sterilization in male rats. The results suggest that an injection method could replace vasectomy as a contraception method. However, this study is a preliminary short-term study of rats. Therefore, a further study of large animals and a clinical study are needed. Moreover, the long-term effectiveness of this method needs to be studied.
